|Podcasts|December 1, 2021
Diagnostic Testing During a Pandemic
Author(s)Nicholas Saraceno, Editor, Michael Christel
A digital health company’s quest to improve the delivery and scaling of lab testing
Advertisement
Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FDA Approves Novo Nordisk’s Wegovy Pill, Marking First Oral GLP-1 for Weight Management
2
Rising Cargo Theft Puts Healthcare Shipments Under Pressure
3
Leveraging Global Scale and Collaboration for Pharma Supply Chain Innovation
4